Preoperative chemoradiotherapy for esophageal cancer

被引：33
|
作者：
Kelsen, D [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2001年 / 19卷 / 02期
关键词：
D O I：
10.1200/JCO.2001.19.2.283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：283 / 285
页数：3
相关论文
共 50 条
  • [31] Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy
    Sakaeda, Toshiyuki
    Yamamori, Motohiro
    Kuwahara, Akiko
    Nishiguchi, Kohshi
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (05) : 388 - 401
  • [32] Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer
    Sugase, Takahito
    Sugimura, Keijiro
    Kanemura, Takashi
    Takeoka, Tomohira
    Yamamoto, Masaaki
    Shinno, Naoki
    Hara, Hisashi
    Omori, Takeshi
    Fujii, Yoshiaki
    Mukai, Yosuke
    Mikamori, Manabu
    Hasegawa, Shinichiro
    Haraguchi, Naotsugu
    Akita, Hirofumi
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    ONCOLOGY, 2022, : 655 - 665
  • [33] Chemoradiotherapy for esophageal squamous cell cancer
    Sasaki, Yusuke
    Kato, Ken
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (09) : 805 - 810
  • [34] Neoadjuvant chemoradiotherapy for esophageal cancer - Is it worthwhile?
    Tamim, WZ
    Davidson, RS
    Quinlan, RM
    O'Shea, MA
    Orr, RK
    Swanson, RS
    ARCHIVES OF SURGERY, 1998, 133 (07) : 722 - 726
  • [35] When randomized trials and observational data disagree: The case of preoperative versus postoperative chemoradiotherapy for esophageal cancer
    Palma, David A.
    Rodrigues, George B.
    Malthaner, Richard
    CANCER, 2013, 119 (11) : 2081 - 2081
  • [36] Phase II study of preoperative chemoradiotherapy with oxaliplatin for locally advance esophageal cancer- final result
    Yeh, H. -L.
    Hsu, C. -P.
    Chuang, C. -Y.
    Chen, C. -C.
    ANNALS OF ONCOLOGY, 2015, 26 : 57 - 57
  • [37] Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer patients using propensity score matching.
    Fujiwara, Yoshinori
    Fukuda, Shuichi
    Tsujie, Masanori
    Kitani, Kotaro
    Yukawa, Masao
    Takeyama, Hiroshi
    Inoue, Masatoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Myelotoxicity of Preoperative Chemoradiotherapy Is a Significant Determinant of Poor Prognosis in Patients With T4 Esophageal Cancer
    Miyoshi, Norikatsu
    Yano, Masahiko
    Takachi, Ko
    Kishi, Kentaro
    Noura, Shingo
    Eguchi, Hidetoshi
    Yamada, Terumasa
    Miyashiro, Isao
    Ohue, Masayuki
    Ohigashi, Hiroaki
    Sasaki, Yo
    Ishikawa, Osamu
    Doki, Yuichiro
    Imaoka, Shingi
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (05) : 302 - 306
  • [39] Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence
    Reigetsu Yoshikawa
    Yoshinori Fujiwara
    Kenji Koishi
    Syoudou Kojima
    Tomohiro Matsumoto
    Hidenori Yanagi
    Takehira Yamamura
    Tomoko Hashimoto-Tamaoki
    Takashi Nishigami
    Tohru Tsujimura
    World Journal of Gastroenterology, 2007, (16) : 2283 - 2288
  • [40] Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence
    Yoshikawa, Reigetsu
    Fujiwara, Yoshinori
    Koishi, Kenji
    Kojima, Syouclou
    Matsumoto, Tomohiro
    Yanagi, Hidenori
    Yamamura, Takehira
    Hashimoto-Tamaoki, Tomoko
    Nishigami, Takashi
    Tsujimura, Tohru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (16) : 2283 - 2288
12345